Psoriasis is a chronic, non-contagious disease that affects the skin and joints. Usually it causes redness and scaly patches appear on the skin.

These scaly spots, caused by psoriasis, called psoriatic plaques (inflamed areas from excessive skin production). Skin rapidly accumulates at these points and takes a silvery-white color. Most commonly they appear on elbows and knees, but can affect any part of the body, including the scalp and genitals. In contrast to eczema, psoriasis is more likely to occur on the indoor side of joint. The cause of psoriasis is unknown, but is believed to have a genetic component.

Factors that may aggravate psoriasis include stress, withdrawal of systemic corticosteroid, excessive alcohol consumption and smoking.

Treatment of psoriasis:

Psoriasis is treated depending on the severity and extent of local derivatives vitamin D and creams steroid until eliminated few small lesions systemic drugs such as cyclosporine, methotrexate and retinoid continuously chorigisineotera biotech drugs called biological agents (anti TNFaRemicade, Enbrel, Humira , anti-IL12 / 23 Stelara, anti IL-17 Cosentyx) provide efficacy and safety in long-term use and use in moderate to severe psoriasis.

When can I see results?

Initial results can be up to 50%  and can be seen with the administration of drugs after 2 months from the start of the treatment. Monitoring patients with Laboratory testing is essential. Now, regarding biological agents, they are effective after 1 month with very high clearance rates such as 90-100%. Biological agents target specific molecules in the path of inflammation and thus treatment is more targeted without the risk of organic toxicity.

Patient monitoring is of course essential to confirm efficacy and safety.